Načítá se...
Physician Decision Making in Selection of Second-Line Treatments in Immune Thrombocytopenia in Children
Immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder which presents with isolated thrombocytopenia and risk of hemorrhage. While most children with ITP promptly recover with or without drug therapy, ITP is persistent or chronic in others. When needed, how to select second-line t...
Uloženo v:
Vydáno v: | Am J Hematol |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
2018
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6037544/ https://ncbi.nlm.nih.gov/pubmed/29659042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25110 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|